ResMed Inc (RMD)

The analysis of ResMed Inc's days of inventory on hand (DOH) over the specified period reveals notable fluctuations. On June 30, 2021, the DOH was approximately 122.87 days, indicating the number of days it typically takes to sell the company's inventory. By June 30, 2022, the DOH increased substantially to roughly 174.75 days, reflecting a longer duration to clear inventory, which may suggest either increased inventory levels or slower sales velocity.

The upward trend continued into June 30, 2023, with DOH reaching approximately 195.08 days. This indicates that inventory turnover slowed further compared to previous years, potentially pointing to inventory management challenges or shifts in demand that could impact working capital efficiency.

Subsequently, there was a decline in DOH by June 30, 2024, to about 147.84 days, suggesting an improvement in inventory turnover efficiency. This reduction may have been driven by better inventory management, increased sales, or strategic adjustments to inventory levels. However, by June 30, 2025, the DOH increased again to approximately 161.91 days, indicating a slight elongation in the period required to sell inventory, though it remained below the peak levels observed in 2023.

Overall, the data depict a period of inventory buildup around 2022-2023, followed by a partial normalization in 2024, and a modest increase in 2025. These trends should be considered in context with sales performance, market conditions, and supply chain factors to form a comprehensive view of ResMed's inventory management efficiency over this timeframe.

Peer comparison

Jun 30, 2025